세계의 망막 박리 시장 규모는 2025-2032년의 예측 기간에 CAGR 6.87%로 성장할 전망입니다. 망막박리 시장은 근시, 당뇨망막병증과 같은 안질환의 급증과 노령 인구 증가 등으로 큰 성장이 예상되고 있습니다. 이러한 추세는 선진국과 신흥 국가 모두에서 안과 의료 서비스에 대한 인식이 높아지고 접근성이 향상됨에 따라 더욱 가속화되고 있습니다. 또한 주요 기업이 수술 결과를 개선하고 안과 의료의 진화하는 요구에 대응하기 위해 혁신적인 기술에 투자하고 제품 개발 활동에 대한 관심이 높아지는 것도 2025-2032년의 예측 기간 중 전체 망막 박리 시장을 증가시킬 것으로 예측되는 요인 중 일부입니다.
망막 박리 시장 역학
특히 젊은 층의 근시 유병률 증가가 망막박리 시장 성장에 크게 기여하고 있습니다. American Academy of Ophthalmology(2024)에 따르면 중국, 일본, 싱가포르, 한국 등의 국가에서는 2024년 청소년과 젊은 성인의 80-90%가 근시를 앓고 있으며, 공중보건상 큰 우려로 떠오르고 있는 급격한 증가세를 보이고 있습니다. 급격한 증가를 보이고 있습니다. 또한 같은 자료는 2050년까지 전 세계 인구의 절반 가까이가 근시가 될 것으로 예측하고 있으며, 이 증상이 광범위하게 퍼져 있음을 강조하고 있습니다. 이를 지원하듯, British Journal of Ophthalmology(2024)에 발표된 연구에 따르면 소아 근시는 전 세계 어린이와 청소년의 약 1/3이 앓고 있으며, 유병률은 인구통계학적 그룹에 따라 차이가 있는 것으로 보고되었습니다. 2050년까지 전 세계 근시 환자 수는 7억 4,000만 명을 넘어설 것으로 예측됩니다. 고도근시가 망막박리의 확립된 위험인자인 만큼, 근시 환자의 지속적인 증가는 망막박리 발병률을 크게 증가시킬 것으로 예측됩니다. 근시는 망막이 늘어나고 얇아지기 때문에 망막열공과 그에 따른 망막박리의 영향을 받기 쉽습니다.
또한 정부의 구상과 안과 기술의 발전은 망막박리 치료 시장의 성장을 가속하고 있습니다. 예를 들어 IAPB가 2022년 8월에 실시한 세계 인식개선 캠페인에서는 10억 명이 넘는 치료받지 못하는 사람들을 위한 안과 치료의 중요성을 강조했습니다. 이러한 노력은 사람들의 인식을 높이고 정기적인 안과 검진과 망막 질환을 조기에 발견할 수 있도록 돕고 있습니다. 이는 OCT, 안저촬영과 같은 진단 툴와 유리체 수술, 공막 버클링과 같은 수술적 개입에 대한 수요를 증가시켜 전체 세계 시장을 촉진할 것으로 보입니다.
또한 노령인구 증가는 망막박리 시장 전체를 더욱 부추기고 있습니다. 세계보건기구(WHO)(202)의 데이터에 따르면 2030년까지 6명 중 1명이 60세 이상이 될 것으로 예상되며, 세계 노령인구는 2020년 10억 명에서 14억 명으로, 2050년까지 21억 명으로 증가할 것으로 예측됩니다. 노인은 일반적으로 후방 유리체 박리(PVD)를 경험하고 종종 망막열공이나 망막원성 박리를 유발하므로 이러한 고령화 추세는 망막박리 시장을 촉진할 수 있습니다. 또한 당뇨병이나 고혈압과 같은 노화와 관련된 만성질환은 견인성 망막박리 및 삼출성 망막박리의 위험을 증가시켜 진단 치료 솔루션 및 수술적 치료 솔루션에 대한 수요를 더욱 촉진합니다.
따라서 위의 요인들이 종합적으로 전체 망막박리 시장의 성장을 가속할 것입니다.
그러나 망막박리 수술에 따른 합병증 등은 망막박리 시장의 성장 과제가 될 수 있습니다.
북미가 전체 망막박리 시장을 독식할 것으로 예측됩니다.
모든 지역 중 북미가 2024년 망막박리 시장을 장악할 것으로 예측됩니다. 이 성장의 주요 원인은 고령화로 인한 근시 및 당뇨병성 망막증 증가입니다. 기타 요인으로는 첨단화된 의료 인프라, 주요 시장 기업의 존재, 지속적인 제품 개발 노력 등을 들 수 있습니다. 이러한 요인들은 예측 기간 중 북미 망막박리 시장의 성장을 가속할 것으로 예측됩니다.
세계의 망막 박리 시장에 대해 조사분석했으며, 시장 규모와 예측, 과거 3년 제품/기술개발, 시장의 주요 기업, 이용 가능한 기회 등의 정보를 제공하고 있습니다.
Retinal Detachment Market by Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, and Exudative Retinal Detachment), Procedure Type (Photocoagulation, Cryopexy, Pneumatic Retinopexy, Scleral Buckling, and Vitrectomy), Product Type (Instruments and Accessories & Consumables), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the surge in eye disorders contributing to the increase in cases of retinal detachment, increasing awareness and access to eye care in developing countries, increase in product development activities among the key market players.
The retinal detachment market is estimated to grow at a CAGR of 6.87% during the forecast period from 2025 to 2032. The retinal detachment market is poised for significant growth due to a surge in eye disorders such as myopia and diabetic retinopathy increase in the geriatric population, among others. This trend is further supported by rising awareness and improved access to eye care services across both developed and emerging economies. Additionally, the market is witnessing a boost from the growing focus on product development activities among key players, who are investing in innovative technologies to enhance surgical outcomes and meet the evolving needs of ophthalmic care are some factors that are expected to escalate the overall retinal detachment market during the forecast period from 2025 to 2032.
Retinal Detachment Market Dynamics:
The rising prevalence of myopia, particularly among younger populations, is significantly contributing to the growth of the retinal detachment market. According to the American Academy of Ophthalmology (2024), in countries such as China, Japan, Singapore, and South Korea, as many as 80% to 90% of teenagers and young adults were affected by myopia in 2024, marking a sharp increase that has emerged as a major public health concern. The same source further projected that by 2050, nearly half of the global population will be myopic, highlighting the widespread nature of this condition. Complementing this, a study published in the British Journal of Ophthalmology (2024) reported that childhood myopia affected roughly one-third of children and adolescents globally, with prevalence rates varying across demographic groups. By 2050, the global number of myopic individuals is expected to exceed 740 million cases. Given that high myopia is a well-established risk factor for retinal detachment, the continued surge in myopia cases is anticipated to substantially increase the incidence of retinal detachment as it stretches and thins the retina, making it more susceptible to retinal tears and subsequent detachment, thereby driving demand for advanced diagnostic tools, surgical interventions, and long-term treatment solutions in the retinal detachment market.
Furthermore, government initiatives and advancements in ophthalmic technology are driving the market growth for retinal detachment treatment. For example, the IAPB's global awareness campaign in August 2022 highlighted the importance of eye care for over 1 billion people lacking treatment access. Such efforts boost public awareness, encouraging regular eye exams and early detection of retinal issues. This increases demand for diagnostic tools like OCT and fundus imaging, as well as surgical interventions such as vitrectomy and scleral buckling thereby boosting the overall market across the world.
Additionally, the increase in the aging population is further boosting the overall market of retinal detachment. According to the data provided by the World Health Organization (202), by 2030, 1 in 6 people is projected to be aged 60 or older, with the global elderly population expected to rise from 1 billion in 2020 to 1.4 billion, and to 2.1 billion by 2050. This aging trend can boost the retinal detachment market, as older adults commonly experience posterior vitreous detachment (PVD), often leading to retinal tears and rhegmatogenous retinal detachment. Additionally, age-related chronic conditions like diabetes and hypertension increase the risk of tractional and exudative retinal detachments, further driving demand for diagnostic and surgical treatment solutions.
Therefore, the factors stated above collectively will drive the overall retinal detachment market growth.
However, the complications associated with retinal detachment surgeries, and others may prove to be challenging factors for retinal detachment market growth.
Retinal Detachment Market Segment Analysis:
Retinal Detachment Market by Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, and Exudative Retinal Detachment), Procedure Type (Photocoagulation, Cryopexy, Pneumatic Retinopexy, Scleral Buckling, and Vitrectomy), Product Type (Instruments and Accessories & Consumables), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the retinal detachment market, the instruments category is expected to have a significant revenue share in the year 2024. The instruments category is playing a pivotal role in boosting the overall market of retinal detachment by driving innovation, improving surgical precision, and expanding the accessibility and success rates of treatment procedures. Instruments such as vitrectomy systems, retinal forceps, micro scissors, illumination probes, laser photocoagulators, and trocar cannulas have become essential tools in the surgical management of retinal detachment. These advanced tools allow ophthalmic surgeons to perform complex procedures such as pars plana vitrectomy, scleral buckling, and pneumatic retinopexy with greater control, reduced surgical time, and minimal trauma to ocular tissues. The availability of minimally invasive and micro-incision surgical instruments has enhanced patient recovery outcomes and encouraged the adoption of these procedures globally, especially in outpatient and ambulatory settings.
Technological improvements in instrument ergonomics, gauge systems (like 25G and 27G), and integrated visualization systems have significantly enhanced the precision and efficiency of retinal detachment surgeries. For instance, high-speed vitrectomy cutters and endoillumination systems improve the safety of procedures by offering clearer visualization of the retina, enabling surgeons to address even subtle retinal tears or detachments. Moreover, the integration of fluidics control digitally assisted visualization, and multifunctional probes in surgical platforms has allowed for better management of complex detachments, including those caused by trauma or diabetic retinopathy. For example, Alcon Constellation(R) Vision System, integrates advanced fluidics control, high-speed vitrectomy cutting, illuminated visualization, and multi-functional dual-mode probes into a single surgical platform. These advancements not only improve surgical outcomes but also reduce the risk of complications and recurrence, making surgery more appealing to both patients and providers. Additionally, in April 2025, Alcon, a global leader in eye care committed to helping people see brilliantly, announced the launch of its UNITY(R) Vitreoretinal Cataract System (VCS) and UNITY(R) Cataract System (CS).
Overall, the instruments category is expected to boost the overall market of retinal detachment during the forecast period from 2025 to 2032.
North America is expected to dominate the overall retinal detachment market:
Among all the regions, North America is expected to dominate the retinal detachment market in the year 2024. This growth is primarily driven by the rising cases of myopia and diabetic retinopathy, largely due to an aging population. Additional contributing factors include a well-established and advanced healthcare infrastructure, the strong presence of key market players, and ongoing product development initiatives. Collectively, these factors are expected to propel the expansion of the retinal detachment market across the North American region during the forecast period.
According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021, it was estimated that in the United States, around 9.6 million people with diabetes, or 2.6%, had diabetic retinopathy (DR), and 1.84 million, or 5.1% of those with diabetes, had vision-threatening diabetic retinopathy (VTDR).
Additionally, as per the same source, in 2021, an estimated 9.6 million people in the U.S. were living with diabetic retinopathy (DR), including 1.84 million with vision-threatening DR. Among individuals with diabetes, the lowest DR prevalence was observed in those under 25 years (13.0%) and the highest in the 65-79 age group (28.4%). Additionally, 8.94 million people aged 40 and above had DR, and 1.71 million in this age group had vision-threatening DR. Thus, the growing prevalence of diabetic retinopathy and its progression to vision-threatening stages is driving the market for retinal detachment treatments. As diabetic complications damage the retina, the demand for advanced surgical interventions, diagnostic tools, and preventive therapies increases, supporting the expansion of the retinal detachment market in the healthcare sector.
The well-established healthcare services and infrastructure further contribute to the growth of the regional retinal detachment market growth. The presence of key players such as Carl Zeiss Meditec AG, IRIDEX Corporation, FCI, and Bausch + Lomb among others with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America retinal detachment market.
Retinal Detachment Market Key Players:
Some of the key market players operating in the retinal detachment market include Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd., FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., Welch Allyn, Baxter, Canon Medical Systems Corporation, Centervue SpA., Essilor International, Eyenuk Inc., HealPros LLC, ONL Therapeutics, Peek Vision Ltd., Synergy Medical Systems LLP, Bausch + Lomb, STAAR Surgical, and others.
Recent Developmental Activities in the Retinal Detachment Market:
Key takeaways from the retinal detachment market report study:
Target audience who can benefit from this retinal detachment market report study:
Frequently Asked Questions for the Retinal Detachment Market: